At the news
? NEUTRALIMPACT 2/10 8-K filed May 8, 2026 at 16:01 ET
Healthequity amended employment agreements for six top executives (including CEO and CFO) to enhance severance benefits, such as additional target bonus payments upon termination without cause or following a change in control. The filing also details new vesting terms for equity awards. This is a routine compensatory arrangement with no material financial impact.
- CEO Scott Cutler's severance enhanced to 12 months base salary plus target bonus (or 18 months base plus 150% bonus upon change in control).
- Other executives (CFO, founder, CCO, CPO, GC) receive 12 months base salary plus target bonus upon change in control.
- New equity vesting terms: RSUs vest on termination without cause; PSUs prorated and remain eligible based on performance.
- No departures or appointments; all executives remain in place.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access